zydus-lifesciences-ltd
Home
Zydus Lifesciences Ltd
ZYDUSLIFE Share Price
BSE:
NSE:ZYDUSLIFE
ZYDUSLIFE Share Price
BSE:
NSE:ZYDUSLIFE
Pharmaceuticals
Large Cap
₹-
0 (0%)
Market Cap
₹98,077.63 Cr
PE Ratio
22.93
Zydus Lifesciences Ltd Performance
▲
▲
▲
▲
Zydus Lifesciences Ltd Fundamentals
Zydus Lifesciences Ltd Futures
| Monthly Contracts | Days For Expiry | Last Traded Price | Volume |
|---|---|---|---|
| Zydus Lifesciences Ltd 26 Dec 2024 | 15 | 991.65 | 945 |
| Zydus Lifesciences Ltd 30 Jan 2025 | 50 | 998.95 | 106 |
| Zydus Lifesciences Ltd 27 Feb 2025 | 78 | 1004.05 | 32 |
Zydus Lifesciences Ltd Options Snapshot
Zydus Lifesciences Ltd Delivery and Volume
About Zydus Lifesciences Ltd
Zydus Lifesciences Ltd. (Formerly known as Cadila Healthcare Ltd.) is one of the leading innovation driven pharmaceutical companies
in India with presence across the pharmaceutical value chain including innovating (research & development), manufacturing,
marketing and selling of finished dosage hu
| Name | Designation |
|---|---|
| Pankaj R Patel | Chairman (Non-Executive) |
| Sharvil P Patel | Managing Director |
| Mukesh M Patel | Non Executive Director |
| H Dhanrajgir | Director |
| A S Diwanji | Director |
| Apurva S Diwanji | Independent Director |
| Upen H Shah | Company Secretary |
| Ganesh N Nayak | Whole-time Director |
| Nitin Raojibhai Desai | Director |
| Bhadresh K Shah | Independent Director |
| Dhaval N Soni | Company Sec. & Compli. Officer |
| Akhil A. Monappa | Independent Director |
| Upasana Konidela. | Independent Director |
| Shelina P. Parikh | Independent Director |
News and Events...
Top Gainers Today
View All
Top Losers Today
View All
Zydus Lifesciences Ltd FAQs
How do I Buy Zydus Lifesciences Ltd Shares?
By opening a demat account and having your KYC papers confirmed online, you may simply purchase Zydus Lifesciences Ltd shares in BlinkX.
What is the Share Price of Zydus Lifesciences Ltd?
The share price of any stock is volatile and changes during the day due to a variety of variables. Zydus Lifesciences Ltd's share price is ₹988.75 as of 2024-12-11.
What is the PE ratio of Zydus Lifesciences Ltd?
Zydus Lifesciences Ltd's P/E ratio is 22.93 times as of 2024-12-11.
What is the PB ratio of Zydus Lifesciences Ltd?
Zydus Lifesciences Ltd's most recent financial reports indicate a price-to-book ratio of 4.49, showing the company's stock market valuation in relation to the value of its real assets.
What is the Market Cap of Zydus Lifesciences Ltd?
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Zydus Lifesciences Ltd's market capitalization is ₹98077.63 Cr as on 2024-12-11.
What is the ROE of Zydus Lifesciences Ltd?
The current financial records of Zydus Lifesciences Ltd show a 23.45% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
What is the Total Asset of Zydus Lifesciences Ltd?
According to Zydus Lifesciences Ltd's most recent financial filings, the company has a total asset value of ₹8091.2, which includes current and non-current assets such as inventory, cash, properties, and equipment.
What is the 52-week high and Low of Zydus Lifesciences Ltd?
The 52-week high/low price of a Zydus Lifesciences Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Zydus Lifesciences Ltd's 52-week high and low as of 2024-12-11 are ₹993.5 and ₹975, respectively.
